Bridging the Design-to-Manufacturing Gap in Medical Devices

Resources

Bridging the Design-to-Manufacturing Gap in Medical Devices

TL;DR

  • Design transfer should run throughout development, not just at the end.
  • Early manufacturing involvement prevents redesigns and delays.
  • “Fit-to-learn” builds are strategic only when temporary.
  • Cross-functional collaboration drives scalability and quality.
  • Continuous design transfer links innovation to market readiness.

Rethinking Design Transfer in Medical Device Development

Your team is ready for design validation. The prototype performs well, test plans are in motion, and everything points to a smooth handoff to manufacturing. Then your partner calls with bad news: they can’t build the device as designed. Overnight, momentum shifts to damage control, bringing delays, redesigns, and rising costs. For many startups, setbacks like this push time-to-market beyond recovery, where technical progress stops translating into company value.

Many companies fall into this trap, treating design transfer as a final handoff before production instead of a bridge between development and manufacturing readiness. But here’s the catch: design validation units must be built in a production environment using real design outputs and quality controls. If manufacturability issues surface at this stage, it’s already too late.

When design transfer happens too late, teams face missed milestones, redesigns, and costly delays. Some organizations intentionally accept design compromises that raise costs or limit scalability. Early in a launch, that can be a strategic choice. These early “fit-to-learn” builds validate product-market fit and generate clinical or market feedback.

The key is to make those trade-offs consciously and temporarily, with a clear plan to refine the design once the value proposition and market alignment are validated.  When compromises persist beyond early validation, they shift from strategic to constraining. even strong technologies stall when cost and scalability barriers limit market adoption.

Why Design Transfer Fails When Treated as a Handoff

Design transfer isn’t a single handoff at the end of development. It’s a continuous process that guides how a product moves from prototype to production. When teams wait too long to involve manufacturing, problems surface late, triggering redesigns and production delays. The result is a reactive scramble that erodes time, trust, and budget between development and manufacturing.

How to Integrate Manufacturing Early

Successful design transfer depends on who’s involved early. Design teams focus on ensuring outputs meet inputs (and rightly so), But they don’t always prioritize design for manufacturability. That’s where new product introduction (NPI) and manufacturing engineers add real value. Their perspective on how to build at scale, test on the line, and maintain devices ensures manufacturability is built in from the start.

Involving them early not only improves prototype design but also builds buy-in from the manufacturing team long before time pressure sets in. When development and production collaborate from the beginning, design transfer becomes a shared objective rather than a final hurdle.

Jasmine is an NPI Engineer with over 12 years of experience in medical device development. She specializes in late-stage design, turning early concepts into market-ready products.

Images: Adobe Stock

Medical device pilot manufacturing workspace showing engineers supporting NPI and scalable production

In MedTech, success rarely comes from invention alone. Plenty of promising technologies make it through verification and early clinical work, only to stall when the team tries to turn them into something buildable.

Thumbnail showing bacterial growth from one cell to 10²¹ cells, illustrating rapid bacteria reproduction with text reading “This fast?” and a red arrow indicating exponential increase.

From how much of your body is actually bacterial to how fast microbes can multiply, these facts are designed to stick with you long after the party ends.

Engineer reviewing a systems workflow diagram representing proportional verification planning in medical device development

In medical device development, verification is both a safeguard and a stress test, not just for the product, but for the process.

Cross-functional MedTech team discussing requirements on a tablet during a medical device development meeting.

In the world of medical device development, requirements are often treated as a regulatory tax, essentially documentation created solely to satisfy a compliance need.